Global Prophylactic Human Vaccine Market Research Report 2024

Publisher Name :
Date: 10-Jan-2024
No. of pages: 78
Inquire Before Buying

Vaccination in The body of a healthy person causes The person to produce antibodies and obtain specific immunity in The absence of disease. For example, BCG vaccination, smallpox vaccination and so on.

The global Prophylactic Human Vaccine market was valued at US$ 193 million in 2023 and is anticipated to reach US$ 144.2 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and The rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, The industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in The market and ensure their products reach patients in need. Additionally, The COVID-19 pandemic has highlighted The importance of vaccine development and supply chain management, further emphasizing The need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of The global market for Prophylactic Human Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess The market competitive situation, analyze their position in The current marketplace, and make informed business decisions regarding Prophylactic Human Vaccine.

Report Scope

The Prophylactic Human Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as The base year, with history and forecast data for The period from 2019 to 2030. This report segments The global Prophylactic Human Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of The market, The report provides profiles of The competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help The Prophylactic Human Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on The revenues, sales volume, and average price for The overall market and The sub-segments across The different segments, By Company, by Type, by Application, and By Regions.

Market Segmentation

By Company

- GSK

- Biovac

- McKesson Medical

- Merck

- Merial

- Zoetis

- Sanofi

Segment by Type

- Inactivated Vaccine

- Attenuated Vaccine

- Others

Segment by Application

- Hospital

- Scientific Research

- Others

Consumption By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Chapter Outline

Chapter 1: Introduces The Report Scope of The report, executive summary of different market segments (

By Region, by Type, by Application, etc), including The market size of each market segment, future development potential, and so on. It offers a high-level view of The current state of The market and its likely evolution in The short to mid-term, and long term.

Chapter 2: Detailed analysis of Prophylactic Human Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Prophylactic Human Vaccine in regional level and country level. It provides a quantitative analysis of The market size and development potential of each region and its main countries and introduces The market development, future development prospects, market space, and market size of each country in The world.

Chapter 4: Provides The analysis of various market segments by Type, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different market segments.

Chapter 5: Provides The analysis of various market segments by Application, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing The basic situation of The main companies in The market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including The upstream and downstream of The industry.

Chapter 8: Introduces The market dynamics, latest developments of The market, The driving factors and restrictive factors of The market, The challenges and risks faced by manufacturers in The industry, and The analysis of relevant policies in The industry.

Chapter 9: The main points and conclusions of The report.

Global Prophylactic Human Vaccine Market Research Report 2024

Table of Contents
1 Prophylactic Human Vaccine Market Overview
1.1 Product Overview and Scope of Prophylactic Human Vaccine
1.2 Prophylactic Human Vaccine Segment by Type
1.2.1 Global Prophylactic Human Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Inactivated Vaccine
1.2.3 Attenuated Vaccine
1.2.4 Others
1.3 Prophylactic Human Vaccine Segment by Application
1.3.1 Global Prophylactic Human Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Prophylactic Human Vaccine Market Size Estimates and Forecasts
1.4.1 Global Prophylactic Human Vaccine Revenue 2019-2030
1.4.2 Global Prophylactic Human Vaccine Sales 2019-2030
1.4.3 Global Prophylactic Human Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Prophylactic Human Vaccine Market Competition by Manufacturers
2.1 Global Prophylactic Human Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Prophylactic Human Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Prophylactic Human Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Prophylactic Human Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prophylactic Human Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prophylactic Human Vaccine, Product Type & Application
2.7 Prophylactic Human Vaccine Market Competitive Situation and Trends
2.7.1 Prophylactic Human Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prophylactic Human Vaccine Players Market Share by Revenue
2.7.3 Global Prophylactic Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prophylactic Human Vaccine Retrospective Market Scenario by Region
3.1 Global Prophylactic Human Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Prophylactic Human Vaccine Global Prophylactic Human Vaccine Sales by Region: 2019-2030
3.2.1 Global Prophylactic Human Vaccine Sales by Region: 2019-2024
3.2.2 Global Prophylactic Human Vaccine Sales by Region: 2025-2030
3.3 Global Prophylactic Human Vaccine Global Prophylactic Human Vaccine Revenue by Region: 2019-2030
3.3.1 Global Prophylactic Human Vaccine Revenue by Region: 2019-2024
3.3.2 Global Prophylactic Human Vaccine Revenue by Region: 2025-2030
3.4 North America Prophylactic Human Vaccine Market Facts & Figures by Country
3.4.1 North America Prophylactic Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Prophylactic Human Vaccine Sales by Country (2019-2030)
3.4.3 North America Prophylactic Human Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prophylactic Human Vaccine Market Facts & Figures by Country
3.5.1 Europe Prophylactic Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Prophylactic Human Vaccine Sales by Country (2019-2030)
3.5.3 Europe Prophylactic Human Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prophylactic Human Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Prophylactic Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Prophylactic Human Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Prophylactic Human Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prophylactic Human Vaccine Market Facts & Figures by Country
3.7.1 Latin America Prophylactic Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Prophylactic Human Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Prophylactic Human Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prophylactic Human Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Prophylactic Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Prophylactic Human Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Prophylactic Human Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Prophylactic Human Vaccine Sales by Type (2019-2030)
4.1.1 Global Prophylactic Human Vaccine Sales by Type (2019-2024)
4.1.2 Global Prophylactic Human Vaccine Sales by Type (2025-2030)
4.1.3 Global Prophylactic Human Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Prophylactic Human Vaccine Revenue by Type (2019-2030)
4.2.1 Global Prophylactic Human Vaccine Revenue by Type (2019-2024)
4.2.2 Global Prophylactic Human Vaccine Revenue by Type (2025-2030)
4.2.3 Global Prophylactic Human Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Prophylactic Human Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Prophylactic Human Vaccine Sales by Application (2019-2030)
5.1.1 Global Prophylactic Human Vaccine Sales by Application (2019-2024)
5.1.2 Global Prophylactic Human Vaccine Sales by Application (2025-2030)
5.1.3 Global Prophylactic Human Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Prophylactic Human Vaccine Revenue by Application (2019-2030)
5.2.1 Global Prophylactic Human Vaccine Revenue by Application (2019-2024)
5.2.2 Global Prophylactic Human Vaccine Revenue by Application (2025-2030)
5.2.3 Global Prophylactic Human Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Prophylactic Human Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Prophylactic Human Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Biovac
6.2.1 Biovac Corporation Information
6.2.2 Biovac Description and Business Overview
6.2.3 Biovac Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Biovac Prophylactic Human Vaccine Product Portfolio
6.2.5 Biovac Recent Developments/Updates
6.3 McKesson Medical
6.3.1 McKesson Medical Corporation Information
6.3.2 McKesson Medical Description and Business Overview
6.3.3 McKesson Medical Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 McKesson Medical Prophylactic Human Vaccine Product Portfolio
6.3.5 McKesson Medical Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Prophylactic Human Vaccine Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Merial
6.5.1 Merial Corporation Information
6.5.2 Merial Description and Business Overview
6.5.3 Merial Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merial Prophylactic Human Vaccine Product Portfolio
6.5.5 Merial Recent Developments/Updates
6.6 Zoetis
6.6.1 Zoetis Corporation Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zoetis Prophylactic Human Vaccine Product Portfolio
6.6.5 Zoetis Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Prophylactic Human Vaccine Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prophylactic Human Vaccine Industry Chain Analysis
7.2 Prophylactic Human Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prophylactic Human Vaccine Production Mode & Process
7.4 Prophylactic Human Vaccine Sales and Marketing
7.4.1 Prophylactic Human Vaccine Sales Channels
7.4.2 Prophylactic Human Vaccine Distributors
7.5 Prophylactic Human Vaccine Customers
8 Prophylactic Human Vaccine Market Dynamics
8.1 Prophylactic Human Vaccine Industry Trends
8.2 Prophylactic Human Vaccine Market Drivers
8.3 Prophylactic Human Vaccine Market Challenges
8.4 Prophylactic Human Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Prophylactic Human Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Prophylactic Human Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Prophylactic Human Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Prophylactic Human Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Prophylactic Human Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Prophylactic Human Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Prophylactic Human Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Prophylactic Human Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Prophylactic Human Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Prophylactic Human Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Prophylactic Human Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Prophylactic Human Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Prophylactic Human Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prophylactic Human Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Prophylactic Human Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Prophylactic Human Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Prophylactic Human Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Prophylactic Human Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Prophylactic Human Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Prophylactic Human Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Prophylactic Human Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Prophylactic Human Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Prophylactic Human Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Prophylactic Human Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Prophylactic Human Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Prophylactic Human Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Prophylactic Human Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Prophylactic Human Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Prophylactic Human Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Prophylactic Human Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Prophylactic Human Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Prophylactic Human Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Prophylactic Human Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Prophylactic Human Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Prophylactic Human Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Prophylactic Human Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Prophylactic Human Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Prophylactic Human Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Prophylactic Human Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Prophylactic Human Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Prophylactic Human Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Prophylactic Human Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Prophylactic Human Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Prophylactic Human Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Prophylactic Human Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Prophylactic Human Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Prophylactic Human Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Prophylactic Human Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Prophylactic Human Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Prophylactic Human Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Prophylactic Human Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Prophylactic Human Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Prophylactic Human Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Prophylactic Human Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Prophylactic Human Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Prophylactic Human Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Prophylactic Human Vaccine Price (USD/Unit) by Type (2019-2024)
Table 59. Global Prophylactic Human Vaccine Price (USD/Unit) by Type (2025-2030)
Table 60. Global Prophylactic Human Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Prophylactic Human Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Prophylactic Human Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Prophylactic Human Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Prophylactic Human Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Prophylactic Human Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Prophylactic Human Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Prophylactic Human Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Prophylactic Human Vaccine Price (USD/Unit) by Application (2019-2024)
Table 69. Global Prophylactic Human Vaccine Price (USD/Unit) by Application (2025-2030)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Prophylactic Human Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. GSK Prophylactic Human Vaccine Product
Table 74. GSK Recent Developments/Updates
Table 75. Biovac Corporation Information
Table 76. Biovac Description and Business Overview
Table 77. Biovac Prophylactic Human Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Biovac Prophylactic Human Vaccine Product
Table 79. Biovac Recent Developments/Updates
Table 80. McKesson Medical Corporation Information
Table 81. McKesson Medical Description and Business Overview
Table 82. McKesson Medical Prophylactic Human Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. McKesson Medical Prophylactic Human Vaccine Product
Table 84. McKesson Medical Recent Developments/Updates
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Prophylactic Human Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Merck Prophylactic Human Vaccine Product
Table 89. Merck Recent Developments/Updates
Table 90. Merial Corporation Information
Table 91. Merial Description and Business Overview
Table 92. Merial Prophylactic Human Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Merial Prophylactic Human Vaccine Product
Table 94. Merial Recent Developments/Updates
Table 95. Zoetis Corporation Information
Table 96. Zoetis Description and Business Overview
Table 97. Zoetis Prophylactic Human Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Zoetis Prophylactic Human Vaccine Product
Table 99. Zoetis Recent Developments/Updates
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Prophylactic Human Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Sanofi Prophylactic Human Vaccine Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Prophylactic Human Vaccine Distributors List
Table 108. Prophylactic Human Vaccine Customers List
Table 109. Prophylactic Human Vaccine Market Trends
Table 110. Prophylactic Human Vaccine Market Drivers
Table 111. Prophylactic Human Vaccine Market Challenges
Table 112. Prophylactic Human Vaccine Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prophylactic Human Vaccine
Figure 2. Global Prophylactic Human Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Prophylactic Human Vaccine Market Share by Type in 2023 & 2030
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Attenuated Vaccine Product Picture
Figure 6. Others Product Picture
Figure 7. Global Prophylactic Human Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Prophylactic Human Vaccine Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Scientific Research
Figure 11. Others
Figure 12. Global Prophylactic Human Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Prophylactic Human Vaccine Market Size (2019-2030) & (US$ Million)
Figure 14. Global Prophylactic Human Vaccine Sales (2019-2030) & (K Units)
Figure 15. Global Prophylactic Human Vaccine Average Price (USD/Unit) & (2019-2030)
Figure 16. Prophylactic Human Vaccine Report Years Considered
Figure 17. Prophylactic Human Vaccine Sales Share by Manufacturers in 2023
Figure 18. Global Prophylactic Human Vaccine Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Prophylactic Human Vaccine Players: Market Share by Revenue in 2023
Figure 20. Prophylactic Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Prophylactic Human Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Prophylactic Human Vaccine Sales Market Share by Country (2019-2030)
Figure 23. North America Prophylactic Human Vaccine Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Prophylactic Human Vaccine Sales Market Share by Country (2019-2030)
Figure 27. Europe Prophylactic Human Vaccine Revenue Market Share by Country (2019-2030)
Figure 28. Germany Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Prophylactic Human Vaccine Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Prophylactic Human Vaccine Revenue Market Share by Region (2019-2030)
Figure 35. China Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Prophylactic Human Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Latin America Prophylactic Human Vaccine Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Prophylactic Human Vaccine Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Prophylactic Human Vaccine Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Prophylactic Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Prophylactic Human Vaccine by Type (2019-2030)
Figure 56. Global Revenue Market Share of Prophylactic Human Vaccine by Type (2019-2030)
Figure 57. Global Prophylactic Human Vaccine Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Prophylactic Human Vaccine by Application (2019-2030)
Figure 59. Global Revenue Market Share of Prophylactic Human Vaccine by Application (2019-2030)
Figure 60. Global Prophylactic Human Vaccine Price (USD/Unit) by Application (2019-2030)
Figure 61. Prophylactic Human Vaccine Value Chain
Figure 62. Prophylactic Human Vaccine Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs